Hisamitsu Pharmaceutical Co., Inc.
HTSUF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | $306,394,199 | $338,800,210 | $270,290,189 | $269,594,294 |
| - Cash | $103,921,000 | $104,107,000 | $114,518,000 | $102,512,000 |
| + Debt | $2,377,000 | $2,646,000 | $3,856,000 | $2,928,000 |
| Enterprise Value | $204,850,199 | $237,339,210 | $159,628,189 | $170,010,294 |
| Revenue | $40,278,000 | $34,665,000 | $44,753,000 | $35,797,000 |
| % Growth | 16.2% | -22.5% | 25% | – |
| Gross Profit | $24,806,000 | $21,286,000 | $24,808,000 | $21,979,000 |
| % Margin | 61.6% | 61.4% | 55.4% | 61.4% |
| EBITDA | $6,511,500 | $0 | $7,258,750 | $5,708,500 |
| % Margin | 16.2% | 0% | 16.2% | 15.9% |
| Net Income | $4,458,000 | $2,564,000 | $8,098,000 | $4,562,000 |
| % Margin | 11.1% | 7.4% | 18.1% | 12.7% |
| EPS Diluted | 61.99 | 35.1 | 110.82 | 62.22 |
| % Growth | 76.6% | -68.3% | 78.1% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |